Current Environment: Production

Medical Services

Programs & Services

Languages

  • English

Education

Undergraduate School

Princeton University

1984, Princeton, NJ

Medical School

University of Wisconsin

1988, Madison, WI

Internship

Beth Israel Deaconess Medical Center

1995, Boston, MA

Residency

Beth Israel Deaconess Medical Center

2000, Boston, MA

Fellowship

Pediatric Radiology

Boston Children's Hospital

2001, Boston, MA

Certifications

  • American Board of Radiology (Diagnostic Radiology)
  • American Board of Radiology (Nuclear Radiology)
  • American Board of Radiology (Pediatric Radiology)

Publications

  1. Update on Surveillance in Von Hippel-Lindau Disease. Clin Cancer Res. 2025 Apr 15. View Abstract

  2. Rasmussen encephalitis: brain MRI and 18F-FDG PET findings. Pediatr Radiol. 2025 May; 55(5):1036-1037. View Abstract

  3. CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL). Radiology. 2025 Jan; 314(1):e232650. View Abstract

  4. Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes. Clin Cancer Res. 2024 Nov 15; 30(22):5021-5033. View Abstract

  5. Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241. View Abstract

  6. Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary Statement. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):669-680. View Abstract

  7. Correction to: Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatr Radiol. 2024 May; 54(5):862. View Abstract

  8. Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation. JCI Insight. 2024 Feb 22; 9(4). View Abstract

  9. Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatr Radiol. 2024 05; 54(5):671-683. View Abstract

  10. A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatr Blood Cancer. 2024 Mar; 71(3):e30817. View Abstract

  11. Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH. Blood Adv. 2023 Oct 24; 7(20):6303-6319. View Abstract

  12. Use of intraoperative bone scintigraphy for resection of spinal osteoid osteoma. Pediatr Radiol. 2023 11; 53(12):2424-2433. View Abstract

  13. Reconsidering pregnancy screening policies for minors: patient-specific estimate of fetus and effective dose for potentially pregnant minors undergoing optimized dose CT of the pelvis. Pediatr Radiol. 2023 09; 53(10):2054-2059. View Abstract

  14. 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematol Oncol. 2023 Jun; 41 Suppl 2:71-73. View Abstract

  15. Yoga, aerobic and stretching exercise effects on neurocognition: Randomized controlled trial protocol. Contemp Clin Trials. 2023 08; 131:107240. View Abstract

  16. Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2023 08; 70(8):e30418. View Abstract

  17. SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations. Pediatr Radiol. 2023 06; 53(7):1443-1453. View Abstract

  18. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1025-1030. View Abstract

  19. Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer. 2023 06; 70 Suppl 4:e30013. View Abstract

  20. Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal Ingestion. Dig Dis Sci. 2023 02; 68(2):541-553. View Abstract

  21. Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1. JCO Precis Oncol. 2022 06; 6:e2200099. View Abstract

  22. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy. Histopathology. 2022 Aug; 81(2):215-227. View Abstract

  23. 68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Pediatr Blood Cancer. 2022 08; 69(8):e29740. View Abstract

  24. Stroke after transcatheter aortic valve replacement: A severe complication with low predictability. Catheter Cardiovasc Interv. 2022 05; 99(6):1897-1905. View Abstract

  25. Development and autoregulation of kidney function in children: a retrospective study using 99mTc-MAG3 renography. Pediatr Nephrol. 2022 09; 37(9):2157-2166. View Abstract

  26. Belzutifan, a Potent HIF2a Inhibitor, in the Pacak-Zhuang Syndrome. N Engl J Med. 2021 11 25; 385(22):2059-2065. View Abstract

  27. Normative database of postural sway measures using inertial sensors in typically developing children and young adults. Gait Posture. 2021 10; 90:112-119. View Abstract

  28. Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome. J Endocr Soc. 2021 Sep 01; 5(9):bvab098. View Abstract

  29. Response to Febo-Rodriguez et al. Am J Gastroenterol. 2021 07 01; 116(7):1553. View Abstract

  30. Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912). Clin Cancer Res. 2021 07 01; 27(13):3543-3548. View Abstract

  31. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 11; 115(11):1830-1839. View Abstract

  32. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 Aug 19. View Abstract

  33. Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group. Pediatr Blood Cancer. 2020 09; 67(9):e28361. View Abstract

  34. Neck CT angiography examinations for pediatric oropharyngeal trauma: diagnostic yield and proposal of a new targeted technique. Pediatr Radiol. 2020 10; 50(11):1602-1609. View Abstract

  35. Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study. J Clin Oncol. 2020 08 20; 38(24):2741-2752. View Abstract

  36. Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). Pediatr Blood Cancer. 2020 08; 67(8):e28365. View Abstract

  37. Normative database of spatiotemporal gait parameters using inertial sensors in typically developing children and young adults. Gait Posture. 2020 07; 80:206-213. View Abstract

  38. Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH). Pediatr Blood Cancer. 2020 04; 67(4):e28142. View Abstract

  39. Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). Clin Cancer Res. 2020 03 15; 26(6):1213-1219. View Abstract

  40. Functional and anatomical imaging in pediatric oncology: which is best for which tumors. Pediatr Radiol. 2019 10; 49(11):1534-1544. View Abstract

  41. Surveillance imaging in pediatric lymphoma. Pediatr Radiol. 2019 10; 49(11):1565-1573. View Abstract

  42. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. JAMA. 2019 08 27; 322(8):746-755. View Abstract

  43. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement. Thorac Cardiovasc Surg. 2020 10; 68(7):616-622. View Abstract

  44. Multicenter pre-operative assessment of pediatric ovarian malignancy. J Pediatr Surg. 2019 Sep; 54(9):1921-1925. View Abstract

  45. A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019 06 01; 25(11):3229-3238. View Abstract

  46. Staging and following common pediatric malignancies: MRI versus CT versus functional imaging. Pediatr Radiol. 2018 08; 48(9):1324-1336. View Abstract

  47. Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. Cancer. 2018 08 01; 124(15):3210-3219. View Abstract

  48. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 08; 65(8):e27077. View Abstract

  49. Correction to: Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. Pediatr Radiol. 2018 03; 48(3):454. View Abstract

  50. Mid-Term Results After Sternal Reconstruction Using Titanium Plates: Is It Worth It to Plate? Ann Thorac Surg. 2018 06; 105(6):1640-1647. View Abstract

  51. Imaging Optimization in Children. J Am Coll Radiol. 2018 03; 15(3 Pt A):440-443. View Abstract

  52. Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. Pediatr Radiol. 2018 01; 48(1):21-30. View Abstract

  53. How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting. Cancer Imaging. 2017 Nov 07; 17(1):28. View Abstract

  54. Liposuction for Swelling in Patients with Lymphedema. N Engl J Med. 2017 11 02; 377(18):1788-1789. View Abstract

  55. Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Pediatr Blood Cancer. 2018 Feb; 65(2). View Abstract

  56. Role of imaging in the diagnosis of parotid infantile hemangiomas. Int J Pediatr Otorhinolaryngol. 2017 Nov; 102:61-66. View Abstract

  57. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol. 2017 Oct 01; 35(28):3215-3221. View Abstract

  58. Operational and Dosimetric Aspects of Pediatric PET/CT. J Nucl Med. 2017 09; 58(9):1360-1366. View Abstract

  59. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1. Clin Cancer Res. 2017 Jun 15; 23(12):e46-e53. View Abstract

  60. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders. Clin Cancer Res. 2017 Jun 15; 23(12):e54-e61. View Abstract

  61. Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. 2017 Jun 15; 23(12):e68-e75. View Abstract

  62. Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI. Clin Cancer Res. 2017 Jun 01; 23(11):e6-e13. View Abstract

  63. Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatr Blood Cancer. 2017 Nov; 64(11). View Abstract

  64. Hepatocellular Carcinoma in Fanconi-Bickel Syndrome. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):84-90. View Abstract

  65. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. Pediatr Blood Cancer. 2017 Jul; 64(7). View Abstract

  66. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 04; 64(4). View Abstract

  67. Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center. J Clin Endocrinol Metab. 2016 10; 101(10):3856-3862. View Abstract

  68. Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management. Int J Pediatr Otorhinolaryngol. 2016 Jul; 86:218-23. View Abstract

  69. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7. View Abstract

  70. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution. Bioconjug Chem. 2015 Apr 15; 26(4):707-17. View Abstract

  71. Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium. Pediatr Blood Cancer. 2015 Jan; 62(1):45-51. View Abstract

  72. A bioorthogonal small-molecule-switch system for controlling protein function in live cells. Angew Chem Int Ed Engl. 2014 Sep 15; 53(38):10049-55. View Abstract

  73. Generation of an intramolecular three-color fluorescence resonance energy transfer probe by site-specific protein labeling. J Pept Sci. 2014 Feb; 20(2):115-20. View Abstract

  74. Surveillance imaging in pediatric Hodgkin Lymphoma. Curr Hematol Malig Rep. 2013 Sep; 8(3):218-25. View Abstract

  75. Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Mar; 61(3):452-6. View Abstract

  76. Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report. J Clin Oncol. 2013 Aug 20; 31(24):3034-43. View Abstract

  77. The radiographic appearance of split Blake drains: what you see is not necessarily what you get. Pediatr Radiol. 2013 Dec; 43(12):1573-6. View Abstract

  78. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014 Aug; 38(6):693-701. View Abstract

  79. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2013 Oct; 60(10):E113-5. View Abstract

  80. A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children. Child Obes. 2013 Jun; 9(3):252-60. View Abstract

  81. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013 May; 14(6):472-80. View Abstract

  82. Reliable estimation of incoherent motion parametric maps from diffusion-weighted MRI using fusion bootstrap moves. Med Image Anal. 2013 Apr; 17(3):325-36. View Abstract

  83. In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. Med Phys. 2012 Aug; 39(8):4832-9. View Abstract

  84. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jul 20; 30(21):2635-40. View Abstract

  85. Reliable assessment of perfusivity and diffusivity from diffusion imaging of the body. Med Image Comput Comput Assist Interv. 2012; 15(Pt 1):1-9. View Abstract

  86. Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jan 20; 30(3):256-62. View Abstract

  87. A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study. Neuro Oncol. 2011 Aug; 13(8):910-5. View Abstract

  88. Leukemia and lymphoma. Radiol Clin North Am. 2011 Jul; 49(4):767-97, vii. View Abstract

  89. Adrenal cortical tumors in children: factors associated with poor outcome. J Pediatr Surg. 2011 Jun; 46(6):1201-7. View Abstract

  90. Pediatric oncology and the future of oncological imaging. Pediatr Radiol. 2011 May; 41 Suppl 1:S172-85. View Abstract

  91. Quantitative body DW-MRI biomarkers uncertainty estimation using unscented wild-bootstrap. Med Image Comput Comput Assist Interv. 2011; 14(Pt 2):74-81. View Abstract

  92. Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2011 Jan 10; 29(2):208-13. View Abstract

  93. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nucl Med Biol. 2011 Jan; 38(1):29-38. View Abstract

  94. Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol. 2010 Nov 20; 28(33):4969-75. View Abstract

  95. Synovial sarcoma in children: imaging features and common benign mimics. AJR Am J Roentgenol. 2010 Oct; 195(4):1026-32. View Abstract

  96. Diagnostic errors in pediatric radiology. Pediatr Radiol. 2011 Mar; 41(3):327-34. View Abstract

  97. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010 Jun; 45(6):1090-5. View Abstract

  98. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol. 2010 Mar; 34(3):287-99. View Abstract

  99. In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. J Pediatr Surg. 2009 Nov; 44(11):e21-4. View Abstract

  100. The ALARA concept in pediatric oncology. Pediatr Radiol. 2009 Nov; 39(11):1142-6. View Abstract

  101. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2009 Aug; 53(2):162-7. View Abstract

  102. Irinotecan plus temozolomide in children with recurrent or refractory neuroblastoma: A phase II Children's Oncology Group study. J Clin Oncol. 2009 May 20; 27(15_suppl):10011. View Abstract

  103. Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20; 26(30):4921-7. View Abstract

  104. A paradoxical signal intensity increase in fatty livers using opposed-phase gradient echo imaging with fat-suppression pulses. Pediatr Radiol. 2008 Oct; 38(10):1099-104. View Abstract

  105. Prenatal diagnosis and subsequent treatment of an intermediate-risk paraspinal neuroblastoma: case report and review of the literature. Fetal Diagn Ther. 2008; 24(2):119-25. View Abstract

  106. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci U S A. 2007 Oct 30; 104(44):17489-93. View Abstract

  107. Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findings. Pediatr Radiol. 2007 Dec; 37(12):1278-82. View Abstract

  108. 3D multidetector CT angiographic evaluation of extralobar pulmonary sequestration with anomalous venous drainage into the left internal mammary vein in a paediatric patient. Br J Radiol. 2006 Sep; 79(945):e99-102. View Abstract

  109. The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disease. Clin Nucl Med. 2006 Jul; 31(7):414-7. View Abstract

  110. On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy cream. Magn Reson Imaging. 2005 Jul; 23(6):757-64. View Abstract

  111. Thymoma in a child: case report and review of the literature. Pediatr Surg Int. 2005 Jul; 21(7):548-51. View Abstract

  112. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 Mar; 57(3):445-52. View Abstract

  113. Right ventricular pseudoaneurysm after modified Norwood procedure. Ann Thorac Surg. 2004 Oct; 78(4):e72-3. View Abstract

  114. An integrated vector system for cellular studies of phage display-derived peptides. Anal Biochem. 2002 Sep 15; 308(2):364-72. View Abstract

  115. Solitary osteosclerotic plasmacytoma: association with demyelinating polyneuropathy and amyloid deposition. Skeletal Radiol. 2001 Sep; 30(9):527-9. View Abstract

  116. Chronic inflammatory pseudotumor arising in the hepatobiliary-pancreatic system: progressive multisystemic organ involvement in four patients. AJR Am J Roentgenol. 1999 Oct; 173(4):1049-54. View Abstract

  117. Gene therapy: a primer for radiologists. Radiographics. 1998 Nov-Dec; 18(6):1343-72. View Abstract

  118. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol. 1998 Sep 15; 161(6):2780-90. View Abstract

  119. Participation of the CD94 receptor complex in costimulation of human natural killer cells. J Immunol. 1998 Feb 15; 160(4):1618-26. View Abstract

  120. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J Immunol. 1997 Sep 01; 159(5):2154-60. View Abstract

  121. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat Immun. 1996-1997; 15(5):213-26. View Abstract

  122. Distinction between gamma c detection and function in YT lymphoid cells and in the granulocyte-macrophage colony-stimulating factor-responsive human myeloid cell line, Tf-1. Blood. 1995 Dec 15; 86(12):4568-78. View Abstract

  123. X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis. Clin Diagn Lab Immunol. 1995 Sep; 2(5):518-23. View Abstract

  124. Addendum to SCID, interleukin-2, and the interleukin-2 receptor review. Blood. 1994 Jul 15; 84(2):667-8. View Abstract

  125. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood. 1994 Feb 01; 83(3):626-35. View Abstract

  126. Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A. 1993 Mar 15; 90(6):2428-32. View Abstract

  127. Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. J Immunol. 1993 Mar 01; 150(5):2046-55. View Abstract

  128. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. J Exp Med. 1992 Aug 01; 176(2):531-41. View Abstract

  129. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8. View Abstract

  130. Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor. Cancer. 1992 Jan 15; 69(2):562-71. View Abstract

  131. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding. J Exp Med. 1990 Oct 01; 172(4):1101-14. View Abstract

  132. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype. Cancer Res. 1990 May 01; 50(9):2683-91. View Abstract

  133. The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment. Bull N Y Acad Med. 1989 Jan; 65(1):93-110. View Abstract

  134. Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation. Cancer Immunol Immunother. 1989; 29(4):261-9. View Abstract
BESbswy